This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Impax Laboratories Inc (IPXL)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 184.61M 142.16M 104.42M 91.80M
Receivables 112.99M 92.25M 153.77M 82.05M
Inventories 70.11M 89.76M 54.18M 44.55M
Other Current Assets 0.00 0.00 1.41M 2.01M
Total Current Assets 659.74M 545.54M 599.94M 520.69M
Property, Plant & Equipment, Gross 287.81M 267.52M 192.96M 168.93M
Accumulated Depreciation & Depletion 99.62M 86.76M 74.80M 62.65M
Property, Plant & Equipment, Net 188.19M 180.76M 118.16M 106.28M
Intangibles 29.67M 47.95M 0.00 0.00
Other Non-Current Assets 57.82M 42.75M 40.76M 33.70M
Total Non-Current Assets 337.18M 318.43M 193.92M 172.62M
Liabilities & Shareholder Equity
Total Assets 996.92M 863.97M 793.86M 693.32M
Accounts Payable 26.82M 41.34M 22.96M 18.81M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 1.54M 1.13M 2.39M
Total Current Liabilities 153.89M 145.30M 156.86M 126.42M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 32.83M 27.57M 33.99M 58.75M
Minority Interest 0.00 0.00 -97.00K -60.00K
Total Non-Current Liabilities 32.83M 27.57M 34.06M 58.92M
Total Liabilities 186.72M 172.87M 190.92M 185.33M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 810.20M 691.10M 602.94M 507.99M
Common Par 699.00K 685.00K 667.00K 647.00K
Additional Paid In Capital 336.65M 314.72M 285.97M 255.44M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 473.87M 372.61M 316.74M 251.25M
Treasury Stock -2.16M -2.16M -2.16M -2.16M
Other Equity Adjustments 1.14M 5.24M 1.72M 2.81M
Total Capitalization 810.20M 691.10M 602.94M 507.99M
Total Equity 810.20M 691.10M 602.94M 507.99M
Total Liabilities & Stock Equity 996.92M 863.97M 793.86M 693.32M
Total Common Shares Outstanding 69.68M 68.27M 66.50M 64.48M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 243.73K 243.73K 243.73K 243.73K
Basic Weighted Shares Outstanding 66.92M 65.66M 64.13M 62.04M
Diluted Weighted Shares Outstanding 68.66M 68.40M 67.32M 65.57M
Number of Employees 973 1125 1002 918
Number of Part-Time Employees 0 0 0 0
IPXL News

IPXL Impax Laboratories Inc

Analysts Ratings for IPXL

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 2
Moderate Buy 0 0 0 0
Hold 5 5 5 4
Moderate Sell 1 1 1 1
Strong Sell 0 0 1 1
GET IPXL ANALYST REPORT

Brokerage Partners

IPXL Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs